# United Therapeutics Corporation (UTHR) FY2026 Q2 Balance Sheet

- Company: United Therapeutics Corporation (UTHR)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001082554-26-000027
- Page: https://plicit.ai/financials/uthr/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/uthr-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 7,220,100,000 US dollars
- **Current assets**: 3,483,700,000 US dollars
- **Non-current assets**: 3,736,400,000 US dollars
- **Liabilities**: 819,800,000 US dollars
- **Current liabilities**: 607,800,000 US dollars
- **Non-current liabilities**: 212,000,000 US dollars
- **Equity**: 6,400,300,000 US dollars
- **Cash and cash equivalents**: 1,803,200,000 US dollars
- **Marketable investments**: 859,100,000 US dollars
- **Other current assets**: 317,300,000 US dollars
- **Accounts receivable, no allowance for 2026 and 2025**: 310,300,000 US dollars
- **Inventories, net**: 193,800,000 US dollars
- **Property, plant, and equipment, net**: 1,930,100,000 US dollars
- **Marketable investments**: 1,141,100,000 US dollars
- **Deferred tax assets, net**: 311,600,000 US dollars
- **Other non-current assets**: 239,500,000 US dollars
- **Goodwill and other intangible assets, net**: 114,100,000 US dollars
- **Accounts payable and accrued expenses**: 497,800,000 US dollars
- **Other current liabilities**: 110,000,000 US dollars
- **Other non-current liabilities**: 212,000,000 US dollars
- **Retained earnings**: 9,164,800,000 US dollars
- **Additional paid-in capital**: 2,895,800,000 US dollars
- **Common stock, par value $0.01, 245,000,000 shares authorized, 78,029,318 and 76,452,253 shares issued, and 42,676,835 and 43,643,165 shares outstanding as of June 30, 2026 and December 31, 2025, respectively**: 800,000 US dollars
- **Preferred stock, par value $0.01, 10,000,000 shares authorized, no shares issued**: 0 US dollars
- **Treasury stock, 35,352,483 and 32,809,088 shares as of June 30, 2026 and December 31, 2025, respectively**: negative 5,644,900,000 US dollars
- **Accumulated other comprehensive (loss) income**: negative 16,200,000 US dollars
- **Gross equity (calculated)**: 12,061,400,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.